Controlled trial of ligation plus vasoconstrictor versus proton pump inhibitor in the control of acute esophageal variceal bleeding

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 4, 2013, Pages 684-689

  Lo, Gin Ho ^a,b   Perng, Daw Shyong ^b   Chang, Chi Yang ^b   Tai, Chi Ming ^b   Wang, Huay Min ^c   Lin, Hui Chen ^b  

^a E DA HOSPITAL   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Banding ligation; Proton pump inhibitor; Vasoconstrictor

Indexed keywords

OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; SOMATOSTATIN; TERLIPRESSIN; VASOCONSTRICTOR AGENT;

ACUTE DISEASE; ACUTE ESOPHAGUS VARICES BLEEDING; ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ENDOSCOPIC SURGERY; ENDOSCOPIC VARICEAL LIGATION; ESOPHAGUS VARICES BLEEDING; FEMALE; HEMOSTASIS; HUMAN; LIGATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT FAILURE;

EID: 84875603904     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12107     Document Type: Article

References (38)

1. Villanueva C, Ortiz J, Sabat M etal. Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial. Hepatology 1993; 30: 384-389.
2. Besson I, Ingrand P, Person B etal. Sclerotherapy with or without octreotide for acute variceal bleeding. N. Engl. J. Med. 1995; 333: 555-560.
3. Avgerinos A, Nevens F, Raptis S etal. Early administration of somatostatin and efficacy of sclerotherapy in acute esophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomized trial. Lancet 1997; 350: 1495-1499.
4. Calés P, Masliah C, Bernard B etal. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N. Engl. J. Med. 2001; 344: 23-28.
5. Lo GH, Chen WC, Wang HM etal. Low-dose terlipressin plus banding ligation vs. low-dose terlipressin alone in the prevention of very early rebleeding of esophageal varices. Gut 2009; 58: 1275-1280.
6. Banares R, Albillos A, Rincon D etal. Endoscopic treatment versus endoscopic plus pharmacologic treatment of acute variceal bleeding: a meta- analysis. Hepatology 2002; 35: 609-615.
7. Bosch J, D'Amico G, Garcia-Pagan JC. Portal hypertension and nonsurgical management. In: Schiff ER, ed. Schiff's Diseases of the Liver, 10th edn. Philadelphia: Lippincott Williams & Wilkins, 2007; 419-483.
8. Lo GH, Lai KH, Cheng JS etal. Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology 1997; 25: 1101-1104.
9. Laine L, Planas R, Nevens F etal. Treatment of acute bleeding episode. In: de Franchis R, ed. Portal Hypertension IV: Proceedings of the Fourth Baveno International Consensus Workshop. Oxford: Blackwell Publishing, 2006; 217-242.
10. Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N. Engl. J. Med. 2010; 362: 823-832.
11. Young MF, Sanowski RA, Rasche R. Comparison and characterization of ulceration induced by endoscopic ligation of esophageal varices versus endoscopic sclerotherapy. Gastrointest. Endosc. 1993; 39: 119-122.
12. Lo GH, Lai KH, Cheng JS etal. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology 1995; 22: 466-471.
13. Lo GH, Lai KH, Cheng JS etal. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology 2000; 32: 461-465.
14. Shaheen NJ, Stuart E, Schmitz SM etal. Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial. Hepatology 2005; 41: 588-594.
15. Lin YT, Lo GH, Lai KH etal. Prophylactic antibiotics in cirrhotics with upper gastrointestinal hemorrhage: a prospective, controlled trial. Zhonghua Yi Xue Za Zhi (Taipei) 2002; 65: 365-371.
16. Hou MC, Lin HC, Liu TT etal. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized controlled trial. Hepatology 2004; 39: 746-753.
17. Lo GH. Management of acute esophageal variceal hemorrhage. Kaohsiung J. Med. Sci. 2010; 26: 55-67.
18. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J. Hepatol. 2000; 33: 846-852.
19. Burroughs AK, Cales P, Kravetz D etal. Definition of key events: last attempt? In: de Franchis R, ed. Portal Hypertension IV: Proceedings of the Fourth Baveno International Consensus Workshop. Oxford: Blackwell Publishing, 2006; 11-39.
20. Bosch J, Abraldes JG, Groszmann R. Current management of portal hypertension. J. Hepatol. 2003; 38: s54-68.
21. Moitinho E, Escorsell A, Bandi JC etal. Prognostic values of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1991; 100: 1403-1410.
22. Mihas AA, Sanyal AJ. Recurrent variceal bleeding despite endoscopic and medical therapy. Gastroenterology 2004; 127: 621-629.
23. de Franchis R. Longer treatment with vasoactive drugs to prevent early variceal rebleeding in cirrhosis. Eur. J. Gastroenterol. Hepatol. 1998; 10: 1041-1044.
24. Lo GH, Chen WC, Chen MH etal. The characteristics and the prognosis for patients presenting with actively bleeding esophageal varices at endoscopy. Gastrointest. Endosc. 2004; 60: 714-720.
25. Sung JJY, Chung SG, Yung MY etal. Prospective, randomized study of effect of octreotide on rebleeding from esophageal varices after endoscopic ligation. Lancet 1995; 346: 16666-16669.
26. Sarin SK, Kumar A, Jha SK etal. Combination of somatostatin plus endoscopic variceal ligation (EVL) is similar to EVL alone in control of acute variceal bleeding: a randomized controlled trial [Abstract]. Hepatology 2008; 628A.
27. Stiegmann GV, Goff JS. Endoscopic esophageal varix ligation: preliminary clinical experience. Gastrointest. Endosc. 1988; 34: 113-117.
28. Lo GH, Lai KH. The factors affecting risk of recurrent variceal bleeding. Gastroenterology 2005; 128: 244.
29. Cheng YS, Pan S, Lien GS etal. Adjuvant sclerotherapy after ligation for the treatment of esophageal varices: a prospective, randomized long-term study. Gastrointest Endosc 2001; 53: 566-571.
30. Villanueva C, Planella M, Aracil C etal. Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonresponders to the usual somatostatin dose. Am. J. Gastroenterol. 2005; 100: 624-630.
31. Garcia-Pagan JC, Caca K, Bureau C etal. Early use of TIPS in patients with cirrhosis and variceal bleeding. N. Engl. J. Med. 2010; 362: 2370-2379.
32. Avgerinos A, Armonis A, Stefanidis G etal. Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis. Hepatology 2004; 39: 1623-1630.
33. Polson RJ, Westaby D, Gimson AES etal. Sucralfate for the prevention of early rebleeding following injection sclerotherapy for esophageal varices. Hepatology 1989; 10: 279-282.
34. Abid S, Jafri W, Hamid S etal. Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial. Am. J. Gastroenterol. 2009; 104: 617-623.
35. Villanueva C, Piqueras M, Aracil C etal. A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding. J. Hepatol. 2006; 45: 560-567.
36. Azam Z, Hamid S, Jafri W etal. Short course adjuvant terlipressin in acute variceal bleeding: a randomized double blind dummy controlled trial. J. Hepatol. 2012; 56: 819-824.
37. Feu F, Arbol LRD, Banares R etal. Double blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Gastroenterology 1998; 111: 1291-1299.
38. Carbonell N, Pauwels A, Serfaty L etal. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004; 40: 652-659.